Alnylam Pharmaceuticals breaks below $300 — now $293.17

Alnylam Pharmaceuticals is currently $293.17. Over 6 months it has slipped 26.82%.

Developing: Alnylam Pharmaceuticals just crossed below $300, a level that tends to draw eyes.

Change across timeframes:

• The past hour: ▼ 3.26% ($303.05 → $293.17) • 24 hours: ▼ 3.26% ($303.05 → $293.17) • 3 days: ▼ 3.26% ($303.05 → $293.17) • 30 days: ▼ 0.83% ($295.63 → $293.17) • 6 months: ▼ 26.82% ($400.59 → $293.17) • A year: ▼ 7.88% ($318.25 → $293.17)

What it means: At $293.17 it sits near the top of its recorded range — higher than 90% of the readings on record. A 26.8% move in a day is unusually large for Alnylam Pharmaceuticals, which typically swings about 1.6% day to day. Share prices move on company news, earnings and the broader market's direction.

Strange company across the desks: Alnylam Pharmaceuticals is currently moving against Kathmandu (weather, +23.1% on the day), and against Shanghai (weather, +14.4% on the day). Correlation isn't causation — but the numbers do dance together.

Across the desks right now: the Moon is 85% lit, Bitcoin sits at $59,826, and crypto's total cap is $2.16T.

In historical context: Alnylam Pharmaceuticals's record high is $491.22, set 8 months ago (Oct 20, 2025); its record low is $6, 14.7 years ago (Oct 3, 2011). It sits 40.3% below its record high and 59% of the way up its all-time range.

Perspective — Benjamin Franklin once observed: “Beware of little expenses; a small leak will sink a great ship.” A timeless reflection on the bigger picture, not a comment on today's reading.

This tracker updates automatically around the clock. The chart above plots its full history.

Source: News Never Sleeps — the AI 24-hour news network. Coverage since Feb 25, 2005. Figures updated continuously, reported as measured.